We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

87:HKEXSwire Pacific Limited Class B Analysis

Data as of 2026-06-13 - not real-time

MYR 0.06

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

S & F Capital Berhad trades at MYR 0.06, just above its 20‑day (MYR 0.0597) and 50‑day (MYR 0.0587) simple moving averages but still below the 200‑day average of MYR 0.0639, indicating a short‑term price bump within a longer‑term downtrend. The RSI of 51.8 and a bullish MACD histogram suggest momentary momentum, yet the stock sits near its technical support at MYR 0.055 with resistance around MYR 0.07, and volume is rising, implying heightened trading activity.
Fundamentally the company is under pressure: revenue fell 22.6%, operating and profit margins are negative, and EBITDA is in the red, while debt (MYR 27.3 m) dwarfs cash (MYR 5.8 m) giving a debt‑to‑equity ratio of 44. The price‑to‑book of 0.63 signals a discount to book value, but the DCF fair value of MYR 0.053 is lower than the current price, suggesting limited upside. High 30‑day volatility (≈78%) combined with a beta of 0.79 and an extreme‑greed market sentiment further accentuates the risk profile.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • Price hovering just above technical support with limited upside to resistance
  • Negative earnings and high debt burden
  • Elevated volatility and increasing volume indicating potential downside pressure

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Discounted price-to-book ratio offering some value cushion
  • Continued operating losses and weak revenue growth
  • Uncertain sector recovery and persistent debt levels

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • Sustained negative profitability and cash‑flow challenges
  • High leverage relative to cash reserves
  • Structural exposure to cyclical real‑estate market in Malaysia

Key Metrics & Analysis

Financial Health

Revenue Growth-22.60%
Profit Margin-25.28%
ROE-7.22%
ROA-1.49%
Debt/Equity44.17
P/B Ratio0.6
Op. Cash FlowMYR-20270838
Free Cash FlowMYR4.8M
Industry P/E33.4

Technical Analysis

TrendNeutral
RSI51.8
SupportMYR 0.05
ResistanceMYR 0.07
MA 20MYR 0.06
MA 50MYR 0.06
MA 200MYR 0.06
MACDBullish
VolumeIncreasing
Fear & Greed Index89.86

Valuation

Fair ValueMYR 0.05
GradeOvervalued
TypeValue

Risk Assessment

Beta0.79
Volatility77.90%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.